• Je něco špatně v tomto záznamu ?

Maternal death by cancer in pregnancy: A descriptive study of the International Network on Cancer, Infertility and Pregnancy

JH. Heimovaara, EA. Huis In 't Veld, CAR. Lok, AC. Garcia, MJ. Halaska, I. Boere, MM. Gziri, R. Fruscio, RC. Painter, E. Cardonick, MM. van den Heuvel-Eibrink, B. Masturzo, K. Van Calsteren, L. van Zuylen, F. Amant, International Network on...

. 2024 ; 131 (12) : 1694-1704. [pub] 20240625

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc25003734

Grantová podpora
13192 CRADLE-II
ZKD6005 Kom op tegen Kanker

OBJECTIVE: To characterise pregnant women diagnosed with primary or recurrent cancer who died during pregnancy, during delivery or within 1 year postpartum. DESIGN: A descriptive study. SETTING: The registry of the International Network on Cancer, Infertility and Pregnancy (INCIP). POPULATION: Women diagnosed with cancer during pregnancy between 2000 and 2022. METHODS: Using the INCIP registry database, we compared the characteristics of all women with cancer who died during pregnancy, delivery or within 1 year postpartum with those of all women with cancer who survived the first year postpartum. MAIN OUTCOME MEASURES: Maternal and tumour characteristics and obstetrical and neonatal outcomes. RESULTS: Of the 2359 women registered in INCIP, there were 131 cases (5.6%) of maternal mortality. Lung cancer (9/14, 64.3% of all registered women with lung cancer), gastro-oesophageal cancer (13/21, 61.9%) and acute leukaemia (17/105, 16.2%) had the highest rates of maternal mortality. Maternal mortality was associated with fewer live births compared with the control group without maternal mortality (99/131, 75.6%, vs 1952/2163, 90.0%; P < 0.001), more elective caesarean sections (64/104, 60.4%, vs 756/1836, 41.2%; P < 0.001) and a lower gestational age at (induced) delivery (34.0 vs 37.1 weeks; P < 0.001), resulting in more preterm births. CONCLUSIONS: Maternal mortality occurred in 5.6% of cancer-in-pregnancy cases and is associated with adverse perinatal outcomes.

Amsterdam Reproduction and Development Amsterdam the Netherlands

Clinic of Obstetrics and Gynaecology University of Milan Bicocca Fondazione IRCCS San Gerardo Monza Italy

Department of Development and Regeneration Unit of Woman and Child KU Leuven Leuven Belgium

Department of Gynaecological Oncology Centre of Gynaecological Oncology Amsterdam Location Antoni van Leeuwenhoek Netherlands Cancer Institute Amsterdam the Netherlands

Department of Medical Oncology Amsterdam University Medical Centre Cancer Centre Amsterdam Vrije Universiteit Amsterdam Amsterdam the Netherlands

Department of Medical Oncology Erasmus MC Cancer Institute Rotterdam the Netherlands

Department of Obstetrics and Gynaecology Amsterdam University Medical Centre Vrije Universiteit Amsterdam The Netherlands

Department of Obstetrics and Gynaecology Cooper University Health Care Camden New Jersey USA

Department of Obstetrics and Gynaecology University of Turin Città Della Salute e Della Scienza Sant'Anna Hospital Turin Italy

Department of Obstetrics Cliniques Universitaires St Luc UCL Sint Lambrechts Woluwe Belgium

Department of Oncology KU Leuven Leuven Belgium

Division of Fetomaternal Medicine Department of Obstetrics and Gynaecology UZ Leuven Leuven Belgium

Division of Gynaecological Oncology Department of Obstetrics and Gynaecology UZ Leuven Leuven Belgium

Hospital Regional de Alta Especialidad de Ixtapaluca 'Reference Clinic for Hemato Oncological Diseases during Pregnancy CREHER' Estado de México Ixtapaluca Mexico

Princess Máxima Centre for Paediatric Oncology Utrecht the Netherlands

University Hospital Kralovske Vinohrady and 3rd Medical Faculty Charles University Prague Czech Republic

University Medical Centre Wilhelmina Children's Hospital Utrecht the Netherlands

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25003734
003      
CZ-PrNML
005      
20250206104645.0
007      
ta
008      
250121s2024 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/1471-0528.17894 $2 doi
035    __
$a (PubMed)38923226
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Heimovaara, Joosje H $u Department of Oncology, KU Leuven, Leuven, Belgium $u Department of Gynaecological Oncology, Centre of Gynaecological Oncology Amsterdam, Location Antoni van Leeuwenhoek - Netherlands Cancer Institute, Amsterdam, the Netherlands $1 https://orcid.org/0000000205502793
245    10
$a Maternal death by cancer in pregnancy: A descriptive study of the International Network on Cancer, Infertility and Pregnancy / $c JH. Heimovaara, EA. Huis In 't Veld, CAR. Lok, AC. Garcia, MJ. Halaska, I. Boere, MM. Gziri, R. Fruscio, RC. Painter, E. Cardonick, MM. van den Heuvel-Eibrink, B. Masturzo, K. Van Calsteren, L. van Zuylen, F. Amant, International Network on Cancer Infertility and Pregnancy
520    9_
$a OBJECTIVE: To characterise pregnant women diagnosed with primary or recurrent cancer who died during pregnancy, during delivery or within 1 year postpartum. DESIGN: A descriptive study. SETTING: The registry of the International Network on Cancer, Infertility and Pregnancy (INCIP). POPULATION: Women diagnosed with cancer during pregnancy between 2000 and 2022. METHODS: Using the INCIP registry database, we compared the characteristics of all women with cancer who died during pregnancy, delivery or within 1 year postpartum with those of all women with cancer who survived the first year postpartum. MAIN OUTCOME MEASURES: Maternal and tumour characteristics and obstetrical and neonatal outcomes. RESULTS: Of the 2359 women registered in INCIP, there were 131 cases (5.6%) of maternal mortality. Lung cancer (9/14, 64.3% of all registered women with lung cancer), gastro-oesophageal cancer (13/21, 61.9%) and acute leukaemia (17/105, 16.2%) had the highest rates of maternal mortality. Maternal mortality was associated with fewer live births compared with the control group without maternal mortality (99/131, 75.6%, vs 1952/2163, 90.0%; P < 0.001), more elective caesarean sections (64/104, 60.4%, vs 756/1836, 41.2%; P < 0.001) and a lower gestational age at (induced) delivery (34.0 vs 37.1 weeks; P < 0.001), resulting in more preterm births. CONCLUSIONS: Maternal mortality occurred in 5.6% of cancer-in-pregnancy cases and is associated with adverse perinatal outcomes.
650    _2
$a lidé $7 D006801
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a těhotenství $7 D011247
650    _2
$a dospělí $7 D000328
650    12
$a nádorové komplikace v těhotenství $x mortalita $7 D011252
650    12
$a registrace $7 D012042
650    12
$a mateřská mortalita $7 D008428
650    _2
$a výsledek těhotenství $x epidemiologie $7 D011256
650    _2
$a nádory $x mortalita $7 D009369
650    _2
$a smrt matky $x statistika a číselné údaje $x etiologie $7 D063130
650    _2
$a novorozenec $7 D007231
655    _2
$a časopisecké články $7 D016428
700    1_
$a Huis In 't Veld, Evangeline A $u Department of Gynaecological Oncology, Centre of Gynaecological Oncology Amsterdam, Location Antoni van Leeuwenhoek - Netherlands Cancer Institute, Amsterdam, the Netherlands $u Princess Máxima Centre for Paediatric Oncology, Utrecht, the Netherlands $1 https://orcid.org/0000000268912255
700    1_
$a Lok, Christianne A R $u Department of Gynaecological Oncology, Centre of Gynaecological Oncology Amsterdam, Location Antoni van Leeuwenhoek - Netherlands Cancer Institute, Amsterdam, the Netherlands $1 https://orcid.org/0000000186937299
700    1_
$a Garcia, Alvaro Cabrera $u Hospital Regional de Alta Especialidad de Ixtapaluca (HRAEI) 'Reference Clinic for Hemato-Oncological Diseases during Pregnancy CREHER' Estado de México, Ixtapaluca, Mexico
700    1_
$a Halaska, Michael J $u University Hospital Kralovske Vinohrady and 3rd Medical Faculty, Charles University, Prague, Czech Republic $1 https://orcid.org/0000000164044537
700    1_
$a Boere, Ingrid $u Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands $1 https://orcid.org/0000000248576346
700    1_
$a Gziri, Mina Mhallem $u Department of Obstetrics, Cliniques Universitaires St Luc, UCL, Sint-Lambrechts-Woluwe, Belgium $1 https://orcid.org/0000000335282389
700    1_
$a Fruscio, Robert $u Clinic of Obstetrics and Gynaecology, University of Milan - Bicocca, Fondazione IRCCS San Gerardo, Monza, Italy $1 https://orcid.org/0000000156882194
700    1_
$a Painter, Rebecca C $u Department of Obstetrics & Gynaecology, Amsterdam University Medical Centre, Vrije Universiteit, Amsterdam, The Netherlands $u Amsterdam Reproduction and Development, Amsterdam, the Netherlands $1 https://orcid.org/0000000193366033
700    1_
$a Cardonick, Elyce $u Department of Obstetrics and Gynaecology, Cooper University Health Care, Camden, New Jersey, USA $1 https://orcid.org/0000000322033367
700    1_
$a van den Heuvel-Eibrink, Marry M $u Princess Máxima Centre for Paediatric Oncology, Utrecht, the Netherlands $u University Medical Centre - Wilhelmina Children's Hospital, Utrecht, the Netherlands $1 https://orcid.org/000000027760879X
700    1_
$a Masturzo, B $u Department of Obstetrics and Gynaecology, University of Turin, Città Della Salute e Della Scienza, Sant'Anna Hospital, Turin, Italy
700    1_
$a Van Calsteren, Kristel $u Division of Fetomaternal Medicine, Department of Obstetrics and Gynaecology, UZ Leuven, Leuven, Belgium $u Department of Development and Regeneration, Unit of Woman and Child, KU Leuven, Leuven, Belgium $1 https://orcid.org/0000000224386783
700    1_
$a van Zuylen, Lia $u Department of Medical Oncology, Amsterdam University Medical Centre, Cancer Centre Amsterdam, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands $1 https://orcid.org/0000000271427605
700    1_
$a Amant, Frederic $u Department of Oncology, KU Leuven, Leuven, Belgium $u Department of Gynaecological Oncology, Centre of Gynaecological Oncology Amsterdam, Location Antoni van Leeuwenhoek - Netherlands Cancer Institute, Amsterdam, the Netherlands $u Division of Gynaecological Oncology, Department of Obstetrics and Gynaecology, UZ Leuven, Leuven, Belgium $1 https://orcid.org/0000000254524905
710    2_
$a International Network on Cancer Infertility and Pregnancy
773    0_
$w MED00005444 $t BJOG $x 1471-0528 $g Roč. 131, č. 12 (2024), s. 1694-1704
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38923226 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250121 $b ABA008
991    __
$a 20250206104640 $b ABA008
999    __
$a ok $b bmc $g 2263482 $s 1239741
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 131 $c 12 $d 1694-1704 $e 20240625 $i 1471-0528 $m BJOG $n BJOG $x MED00005444
GRA    __
$a 13192 $p CRADLE-II
GRA    __
$a ZKD6005 $p Kom op tegen Kanker
LZP    __
$a Pubmed-20250121

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...